Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Albert Einstein College of Medicine
Sun Yat-sen University
Children's Oncology Group
Assistance Publique - Hôpitaux de Paris
Children's Oncology Group
University Hospital, Bonn
Ohio State University Comprehensive Cancer Center
Children's Oncology Group
Children's Oncology Group
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Children's Oncology Group
University of Pittsburgh
Children's Oncology Group
Eli Lilly and Company
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
NYU Langone Health
Duke University
National Institutes of Health Clinical Center (CC)